[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353683-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353683-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","auranofin-combination-therapy-a-new-frontier-in-cancer-treatment-review","Auranofin Combination Therapy - A New Frontier in Cancer Treatment - Review","","Auranofin, a gold(I)-based compound first developed for rheumatoid arthritis, is evaluated as a multimodal anticancer agent. The review assesses how auranofin may synergize with both conventional and emerging cancer treatments, emphasizing thioredoxin reductase inhibition, reactive oxygen species induction, and effects on apoptotic signaling. Evidence from preclinical and clinical studies is used to discuss roles in overcoming drug resistance and supporting adjuvant use in precision medicine.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/auranofin-combination-therapy-a-new-frontier-in-cancer-treatment-review/353683/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/auranofin-combination-therapy-a-new-frontier-in-cancer-treatment-review/353683.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What anticancer mechanisms does auranofin have according to the review?","Question",{"text":63,"@type":64},"The review highlights thioredoxin reductase inhibition, induction of reactive oxygen species, and modulation of key apoptotic pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the review describe auranofin in combination therapy?",{"text":68,"@type":64},"It focuses on auranofin’s ability to synergize with chemotherapy, immunotherapy, and targeted therapies to enhance treatment effects.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is overcoming drug resistance a key emphasis of this review?",{"text":72,"@type":64},"Drug resistance and recurrence/relapse are described as major obstacles; the review discusses how auranofin could help address resistance and support more effective regimens.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353683,1790330496,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nAuranofin Combination Therapy: A New Frontier in Cancer Treatment  \nDiana Laura Guzman-Gomez 1, Srinivasa Reddy Telukutla 1, *, Ruchika Ojha 2, Suresh K. Bhargava 2 and Magdalena Plebanski 1, *  \nAcademic Editors: Burgert Blom and Mauro Ravera  \nReceived: 8 December 2025  \nRevised: 30 January 2026  \nAccepted: 3 February 2026  \nPublished: 6 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Accelerator for Translational Research in Clinical Trials (ATRACT) Centre, School of Health and Biomedical Sciences, STEM College, RMIT University, Melbourne, VIC 3083, Australia; [s4057062@student.rmit.edu.au](s4057062@student.rmit.edu.au)  \n2 Centre for Advanced Materials and Industrial Chemistry, School of Science, STEM College, RMIT University, Melbourne, VIC 3000, Australia; [ruchika.ojha@rmit.edu.au](ruchika.ojha@rmit.edu.au) (R.O.); [suresh.bharagava@rmit.edu.au](suresh.bharagava@rmit.edu.au) (S.K.B.)  \n* Correspondence: [srinivasareddy.telukutla@rmit.edu.au](srinivasareddy.telukutla@rmit.edu.au) (S.R.T.); [magdalena.plebanski@rmit.edu.au](magdalena.plebanski@rmit.edu.au) (M.P.)  \nAbstract  \nAuranofin, a gold(I)-based compound initially developed for the treatment of rheumatoid arthritis, has emerged as a promising anticancer agent with a multimodal mechanism of action. This review comprehensively examines the therapeutic potential of auranofin in oncology focusing on its ability to synergize with conventional and emerging cancer treatments. Here, we discuss the unique pharmacological properties of auranofin, including thioredoxin reductase inhibition, reactive oxygen species induction, and modulation of key apoptotic pathways. Moreover, this article highlights new recent evidence on its ability to synergize with other cancer treatments such as chemotherapy, immunotherapy, and targeted therapies. Particular emphasis is placed on the role of auranofin in overcoming drug resistance and its potential as an adjuvant in precision medicine. By analyzing both preclinical and clinical data, this review provides critical insights into the repositioning of auranofin as a versatile component in contemporary cancer treatment paradigms, while addressing current challenges and future directions for gold-based therapeutics in oncology.  \nKeywords: auranofin; gold therapy; cancer treatment; combination therapy; thioredoxin reductase; oxidative stress  \n1. Introduction  \nCancer is a group of diseases characterized by abnormal cells growing uncontrolledly forming tumors and invading surrounding and distant tissues, the latter known as metastasis. It remains one of the leading causes of death worldwide with an estimated 20 million new cases and nearly 10 million deaths in 2022 [1] . According to global cancer statistics, the most prevalent types of cancer in 2022 are lung (2.48 million cases), breast (2.29 million cases), colorectum (1.92 million) and prostate (1.46 million cases), whereas the most lethal, with 5-year survival post-diagnosis below 50%, include lung, pancreatic, liver, stomach and ovarian cancer. However, factors such as age, sex, geographic location, and socioeconomic status change the distribution of cancer around the world with different impactsand variations across populations [1–5] .  \nCancer poses a significant global health burden due to multiple factors such as lifestyle, environment, genetics and the presence and influence of specific infectious pathogens. Moreover, the lack of appropriate cancer management and palliative care in low resource settings can obstruct the progress and successful implementation of cancer treatments.  \nNevertheless, the disease burden might be reduced by the avoidance of risk factors, improvement of early detection techniques, and novel therapeutic approaches [2,6,7] . Current cancer therapies include surgery, chemotherapy","cbCaik55s74OnBaH","https://ap.wps.com/l/cbCaik55s74OnBaH","pdf",1274524,17,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What anticancer mechanisms does auranofin have according to the review?\",\"answer\":\"The review highlights thioredoxin reductase inhibition, induction of reactive oxygen species, and modulation of key apoptotic pathways.\"},{\"question\":\"How does the review describe auranofin in combination therapy?\",\"answer\":\"It focuses on auranofin’s ability to synergize with chemotherapy, immunotherapy, and targeted therapies to enhance treatment effects.\"},{\"question\":\"Why is overcoming drug resistance a key emphasis of this review?\",\"answer\":\"Drug resistance and recurrence/relapse are described as major obstacles; the review discusses how auranofin could help address resistance and support more effective regimens.\"}]","Auranofin Combination Therapy - A New Frontier in Cancer Treatment - Review | PDF",1790106719,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d0889d1ac419bd4f8cea3b23638d236.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5cdf50e4a62ed55eb2a538039eb601b.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1018211e23b7573f8ba58fbe7d9a130b.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9796830c3dbff74417bcf98e649ca187.webp",980,1385]